Nitric oxide from bench to bedside: A perinatal perspective - Part II

International Journal of Obstetric Anesthesia

Volumn 5, Issue 4, 1996, Pages 244-253

  Davidson, D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE DONOR;

ADULT RESPIRATORY DISTRESS SYNDROME; CONGENITAL HEART DISEASE; DIAPHRAGM HERNIA; DISEASE COURSE; FEMALE; HELLP SYNDROME; HUMAN; MATERNAL DISEASE; NEWBORN; NEWBORN DISEASE; PERIOPERATIVE PERIOD; PERSISTENT FETUS CIRCULATION; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; REVIEW;

EID: 0029908783     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-289X(96)80045-8     Document Type: Review

References (106)

1. Gersony W M, Duc G V, Sinclair J C. 'PFC' Syndrome (Persistence of the fetal circulation). Circulation 1969; 40 (supplement 3): 87 Abstract.
2. Kinsella J P, Abman S H. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995; 126: 853-856.
3. Morin III F C, Stenmark K R. Persistent pulmonary hypertension of the newborn: State of the art. Am J Resp Crit Care Med 1995; 151: 2010-2032.
4. Dawes G, Mott J. The vascular tone of the foetal lung. J Physiol 1962; 164: 4465-4477.
5. Cassin S, Dawes G, Mott J, Ross B, Strang L. The vascular resistance of the foetal and newly ventilated lung of the lamb. J Physiol (London) 1964; 171: 61-79.
6. Teitel D, Iwamoto H, Rudolph A. Changes in the pulmonary circulation during birth-related events. Pediatr Res 1990; 27: 372-378.
7. Rudolph A, Heymann M. Circulatory changes during growth in the fetal lamb. Circ Res 1970; 26: 289-299.
8. Leffler C, Tyler T, Cassin S. Effect of indomethacin on pulmonary vascular response to ventilation of fetal goats. Am J Physiol 1978; 234: H346-H351.
9. Davidson D. Pulmonary hemodynamics at birth: Effect of acute cyclo-oxygenase inhibition in lambs. J Appl Physiol 1988; 64: 1676-1682.
10. Abman S, Chatfield B, Hall S, McMurty I. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259: H1921-H1927.
11. Ivy D D, Kinsella J P, Abman S H. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 1994; 93: 2141-2148.
12. Nelson N M. Respiration and circulation after birth. In: Smith C A, Nelson N M, eds. The Physiology of the Newborn Infant. Springfield IL: Charles Thomas, 1976; 228-231.
13. Clyman R I, Mauray F, Roman C, Heymann M A, Payne B. Factors determining the loss of ductus arteriosus responsiveness to prostaglandin E. Circulation 1983; 68: 433-636.
14. James L S, Rowe R D. The pattern of response of pulmonary and systemic arterial pressure in newborn and older infants to short periods of hypoxia. J Pediatr 1957; 51: 5-11.
15. Weigel T J, Hageman J R. National survey of diagnosis and management of persistent pulmonary hypertension of the newborn. J Perinatol 1990; 10: 369-375.
16. Walsh-Sukys M, Fanaroff A, Wright L et al. Persistent pulmonary hypertension of the newborn (PPHN): Prospective, multi-center study of treatment and outcomes. Pediatr Res 1995; 37: 244A.
17. Murphy J, Vawter G, Reid L. Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 1984; 104: 758-762.
18. Zayek M, Cleveland D, Morin F C. Treatment of persistent pulmonary hypertension of the newborn lamb by inhaled nitric oxide. J Pediatr 1993; 122: 743-750.
19. Finer N N, Etches P C, Kamstra B et al. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994; 124: 302-308.
20. Sahni R, Wung J T, James L S. Controversies in management of persistent pulmonary hypertension of the newborn. Pediatrics 1994; 94: 307-309.
21. Hageman J R, Adams M A, Gardner T H. Pulmonary complications of hyperventilation therapy for persistent pulmonary hypertension. Crit Care Med 1985; 13: 1013-1014.
22. Bifano E M, Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988; 81: 657-661.
23. Hendricks-Munoz K D, Walton J P. Hearing loss in infants with persistent fetal circulation. Pediatrics 1988; 20: 147-150.
24. Goetzman B, Sunshine P, Johnson J et al. Neonatal hypoxia and vasospasm: Response to tolazoline. J Pediatr 1976; 89: 617-621.
25. Stevenson D, Kastings D, Darnall R et al. Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazoline. J Pediatr 1979; 95: 595-599.
26. Clark R H, Yoder B A, Sell M S. Prospective, randomized comparison of high frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994; 124: 447-454.
27. Wung J T, James L S, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 1985; 96: 488-494.
28. Heymann J, Adams A, Gardner T. Persistent pulmonary hypertension of the newborn: Trends, incidence, diagnosis, and management. AJDC 1984; 138: 592-595.
29. Bartlett R H, Roloff D W, Cornell R G, Andrew A F, Dillon P W, Zwischenberger J B. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics 1985; 76: 479-487.
30. O'Rourke P P, Crone R, Vacanti J et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatrics 1989; 84: 957-963.
31. Bernbaum J C, Russell P, Sheridan P H, Gewitz M H, Fox W W, Peckham G. Long-term follow-up of newborns with persistent pulmonary hypertension. Crit Care Med 1984; 12: 579-583.
32. Sell E J, Gaines J A, Gluckman C, Williams E. Persistent fetal circulation: neurodevelopmental outcome. Am J Dis Child 1985; 139: 25-28.
33. Ballard R A, Leonard C A. Developmental follow-up of infants with persistent pulmonary hypertension of the newborn. Clin Perinatol 1984; 11: 737-744.
34. Marron M J, Crisafi M A, Driscoll J M et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 1992; 90: 392-396.
35. Glass P, Miller M, Short B. Morbidity for survivors of extracorporeal membrane oxygenation: Neurodevelopmental outcome at 1 year of age. Pediatrics 1989; 83: 72-78.
36. Kanto W P. A decade of experience with neonatal extracorporeal membrane oxygenation. J Pediatr 1994; 124: 335-347.
37. Fashaw M, Rosenberg A, Kinsella J P, Abman S H, Ivy D, Torielli F M. Neurodevelopmental and medical follow-up of infants with PPHN treated with inhaled nitric oxide. Pediatr Res 1995; 37: 261A.
38. Roberts J D, Polaner D M, Lang P et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819.
39. Kinsella J P, Neish S R, Shafer E, Abman S H. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-820.
40. Kinsella J P, Neish S R, Ivy D D, Schaffer E, Abman S H. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediat 1993; 123: 103-108.
41. Roze J C, Storme L, Zupan V, Morville P, Dinh-Xuan A T, Mercier J C. Echocardiographic investigation of inhaled nitric oxide in newborn babies with severe hypoxemia. Lancet 1994; 344: 303-305.
42. Barefield E S, Karle V A, Philips J B, Carlo W A. Randomized, controlled trial of inhaled NO in ECMO candidates. Pediatr Res 1995; 37: 195A.
43. Auten R L, Notter R H, Kendig J W, Davis J M, Shapiro D L. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991; 87: 101-107.
44. Thusu K G, Steinhorn R H, Morin F C. Inhibition of cGMP specific phosphodiesterase (PDE) decreases the threshold concentration of inhaled nitric oxide (NO) in lambs with persistent pulmonary hypertension of the newborn (PPHN). Pediatr Res 1995; 37: 80A.
45. Nio M, Haase G, Kennaugh J, Bui K, Atkinson J B. A prospective randomized trial of delayed versus immediate repair of congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 618-621.
46. Moffitt S T, Schultze K F, Sahni R, Wung J T, Myers M M, Stolar CJH. Preoperative cardiorespiratory trends in infants with congenital diaphragmatic hernia. J Pediatr Surg 1995; 30: 604-611.
47. Wilcox DT, Glick P L, Karamanoukian H, Rossman J, Morin F C, Holm B A. Pathophysiology of congenital diaphragmatic hernia V. Effect of exogenous surfactant therapy on gas exchange and lung mechanics in the lamb congenital diaphragmatic hernia model. J Pediatr 1994; 124: 289-293.
48. Levin D L. Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia. J Pediatr Surg 1978; 92: 805-811.
49. Geggel R L, Murphy J D, Langleben D. Congenital diaphragmatic hernia: Arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr Surg 1985; 92: 805-810.
50. Short B L. Extracorporeal membrane oxygenation. In: Avery G B, Fletcher M A, MacDonald M G eds. Neonatology: Pathophysiology and Management of the Newborn, 4th ed. Philadelphia: J B Lippincott 1994: 504-515.
51. Shah N, Jacob T, Exler R et al. Inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 1010-1014.
52. Leveque C, Hamza J, Alain B et al. Successful repair of a severe left congenital diaphragmatic hernia during continuous inhaltion of nitric oxide. Anesthesiology 1994; 80: 1171-1175.
53. Karamanoukian H L, Glick P L, Zayek M et al. Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 1994; 94: 715-718.
54. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery. Br Heart J 1995; 73: 65-68.
55. Miller O I, Celermajer D S, Deanfield J E, Macrae D J. Verylow-dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108: 487-494.
56. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107: 1129-1135.
57. Winberg P, Lundell B P, Gustafsson L E. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Br Heart J 1994; 71: 282-286.
58. Wessel D L, Adatia I, Giglia T M, Thompson J E, Kulik T J. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88: 2128-2138.
59. Roberts J D, Lang P, Bigatello L M, Vlahakes G J, Zapol W M. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87: 447-453.
60. Hoffman J I E, Rudolph A M, Heymann M A. Pulmonary vascular disease with congenital heart lesions: Pathologic features and causes. Circulation 1981; 64: 873-877.
61. Rabinovitch M, Haworth S G, Castaneda A R, Nadas A S, Reid L M. Lung biopsy in congenital heart disease: A morphometric approach to pulmonary vascular disease. Circulation 1978; 58: 1107-1122.
62. Haworth S G. Pulmonary vascular disease in different types of congenital heart disease: Implications for interpretation of lung biopsy findings in early childhood. Br Heart J 1984; 52: 557-571.
63. Petty T L. The acute respiratory distress syndrome, historic perspective. Chest 1994; 105: 44S-47S.
64. Ashbaugh D G, Bigelow D B, Petty T L et al. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
65. Petty T L, Ashbaugh D G. The adult respiratory distress syndrome: Clinical features, factors affecting prognosis and principals of management. Chest 1971; 60: 233-239.
66. Bernard G R, Artigas A, Brigham K L et al. The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-824.
67. Slutsky A S. ACCP Consensus Conference: Mechanical ventilation. Chest 1993; 104: 1833-1859.
68. Fowler A A, Hyers T M, Fisher B J et al. The adult respiratory distress syndrome: Cell populations and soluble mediators in the air spaces of patients at high risk. Am Rev Respir Dis 1987; 136: 1225-1231.
69. Bernard G R, Luce J M, Sprung C L et al. High dose corticosteroids in patients with adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565-1570.
70. Meduri U, Kohler G, Headley S, Tolley E, Stentz F, Postletwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Chest 1995; 108: 1303-1314.
71. Meduri U, Headley S, Tolley E, Shelby M, Stentz F, Postletwaite A. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 1995; 108: 1315-1325.
72. Gattinoni L, Presenti A. ARDS: The nonhomogenous lung: Facts and hypothesis. Intensive Crit Care Dig 1987; 6: 1-4.
73. Hankin GDV. Acute respiratory failure. Clin Obstet Gynec 1990; 33: 493-501.
74. Mabie W C, Barton J R, Sibai B M. Adult respiratory distress syndrome in pregnancy. Am J Obstet Gynecol 1992; 167: 950-957.
75. Hankins G D, Nolan T E. Adult respiratory distress syndrome in obstetrics. Obstet Gynecol Clin North Am 1991; 18: 273-87.
76. Smith J L, Thomas F, Orme J F, Clemmer T P. Adult respiratory distress syndrome during pregnancy and immediately postpartum. West J Med 1990; 153: 508-510.
77. Eriksen N L, Paris V M. Adult respiratory distress syndrome and pregnancy. Semin Perinatol 1990; 14: 68-78.
78. de-Veciana M, Towers C V, Major C A, Lien J M, Toohey J S. Pulmonary injury associated with appendicitis in pregnancy: Who is at risk? Am J Obstet Gynecol 1994; 171: 1008-1013.
79. Lapinsky S E, Kruczynski K, Slutsky A S. Critical care in the pregnant patient. Am J Respir Crit Care Med 1995; 152: 427-455.
80. Frostell C, Fratacci M D, Wain J C, Jones R, Zapol W M. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
81. Frostell C, Biomqvist H, Hedenstierna G, Lundberg J, Zapol W M. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78: 427-435.
82. Frattacci M D, Frostell C, Chen T Y, Wain J C, Jones R, Zapol W M. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction in sheep. Anesthesiology 1991; 75: 990-999.
83. Rossaint R, Falke K J, Lopez F, Slama K, Pison U, Zapol W M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
84. Bigatello L M, Hurford W E, Kacmarek R M, Roberts J D, Zapol W M. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 1994; 80: 761-770.
85. Puybasset L, Rouby J J, Murgeon E et al. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Resp Crit Care Med 1995; 152: 318-328.
86. Puybasset L, Stewart T, Rouby J J et al. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 1994; 80: 1254-1267.
87. Radetsky P. Stopping premature births before it's too late. Science 1994; 226: 1486-1488.
88. Yallampalli C, Garfield R E, Byam-Smith M. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 1993; 133: 1899-1902.
89. Yallampalli C, Izumi H, Byam-Smith M, Garfield R E. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 1994; 170: 175-185.
90. Buhimschi I, Yallampalli C, Dong Y L, Garfield R E. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in the control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995; 172: 1577-1584.
91. Telfer J F, Lyall F, Norman J E, Cameron I T. Identification of nitric oxide synthase in human uterus. Hum Reprod 1995; 10: 19-23.
92. Sladek S M, Regenstein A C, Lykins D, Roberts J M. Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol 1993; 169: 1285-1291.
93. Garfield R E, Ali M, Yallampalli C, Izumi H. Role of gap junctions and nitric oxide in control of myometrial contractility. Semin Perinatol 1995; 19: 41-51.
94. Lees C, Campbell S, Jauniaux E et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994; 343: 1325-1326.
95. Symonds E M. Hypertension in pregnancy. Arch Dis Child Fetal Neonatal Ed 1995; 72: F139-F144.
96. Radomski M W, Palmer R M J, Moncada S. The antiaggregating properties of the vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646.
97. Calver A, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 1993; 78: 303-326.
98. Flavahan N A. Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/Nitric oxide activity. Circulation 1992; 85: 1927-1938.
99. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548-2554.
100. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-221.
101. Cockcroft J R, Chowienczyk P J, Benjamin N, Ritter J M. Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-1040.
102. McCarthy A L, Woolfson R G, Raju S K, Poston L. Abnormal endothelial cell function of resistance arteries from women with pre-eclampsia. Am J Obstet Gynecol 1993; 168: 1323-1330.
103. Seligman S P, Buyon J P, Clancy R M, Young B K, Abramson S B. The role of nitric oxide in the pathogenesis of pre-eclampsia. Am J Obstet Gynecol 1994; 171: 944-948.
104. Yallampalli C, Garfield R E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of pre-eclampsia. Am J Obstet Gynecol 1993; 169: 1316-1320.
105. Molar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces susatined hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170: 1458-1466.
106. de-Beider A, Lees C, Martin J, Moncada S, Campbell S. Treatment of HELLP syndrome with nitric oxide donor. Lancet 1995; 345: 124-125.